433 related articles for article (PubMed ID: 25484388)
1. An open label prospective randomized trial to compare the efficacy of coal tar-salicylic Acid ointment versus calcipotriol/betamethasone dipropionate ointment in the treatment of limited chronic plaque psoriasis.
Khandpur S; Sahni K
Indian J Dermatol; 2014 Nov; 59(6):579-83. PubMed ID: 25484388
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh P; Gupta S; Abidi A; Krishna A
J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
4. An Open Label Prospective Randomized Trial to Compare the Efficacy of Coal Tar-salicylic Acid Ointment Versus Calcipotriol/Betamethasone Dipropionate Ointment in the Treatment of Limited Chronic Plaque Psoriasis.
Nast A
Indian J Dermatol; 2015; 60(2):198. PubMed ID: 25814714
[No Abstract] [Full Text] [Related]
5. Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis.
Sharma V; Kaur I; Kumar B
Int J Dermatol; 2003 Oct; 42(10):834-8. PubMed ID: 14521705
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
Tosti A; Piraccini BM; Cameli N; Kokely F; Plozzer C; Cannata GE; Benelli C
Br J Dermatol; 1998 Oct; 139(4):655-9. PubMed ID: 9892909
[TBL] [Abstract][Full Text] [Related]
8. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Yan R; Jiang S; Wu Y; Gao XH; Chen HD
Indian J Dermatol Venereol Leprol; 2016; 82(2):135-44. PubMed ID: 26924402
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
[TBL] [Abstract][Full Text] [Related]
11. Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
Morita A; Muramatsu S; Kubo R; Ikumi K; Sagawa Y; Saito C; Torii K; Nishida E
J Dermatolog Treat; 2018 Aug; 29(5):496-500. PubMed ID: 29076379
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
13. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
[TBL] [Abstract][Full Text] [Related]
14. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
Kaufmann R; Bibby AJ; Bissonnette R; Cambazard F; Chu AC; Decroix J; Douglas WS; Lowson D; Mascaro JM; Murphy GM; Stymne B
Dermatology; 2002; 205(4):389-93. PubMed ID: 12444337
[TBL] [Abstract][Full Text] [Related]
15. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
Vena GA; Galluccio A; Pezza M; Vestita M; Cassano N
J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153
[TBL] [Abstract][Full Text] [Related]
17. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
Kragballe K; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):39-44. PubMed ID: 16405606
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of the Effectiveness and Safety of Topical Calcipotriol and Topical Methotrexate in Chronic Plaque Psoriasis.
Das K; Ranjan R; Kumar P; Chandra S
Cureus; 2024 May; 16(5):e59878. PubMed ID: 38854231
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]